Tizanidine Hydrochloride Capsule
Product Images NDC 46708-491

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 46708-491). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

30 Capsules (Tizanidine 2mg)

30 Capsules (Tizanidine 2mg)
This is a description for Tizanidine Hydrochloride Capsules, containing 229mg of tizanidine hydrochloride per capsule, equivalent to 2mg of tizanidine base. The package insert should be referred to for prescribing information. The medication should be dispensed in child-resistant containers. These capsules are Rx-only and come in a package containing 30 capsules. The medication should be stored at room temperature between 15°C to 30°C (59°F to 86°F). This medication is manufactured by Alerbic Pharmaceuticals Limited (Formation Division) in Panchmatel, Gujarat, India. The manufacturer's NDC number is 46708-491-30. The trademark Zandflex® belongs to Accord Therapeutics, Inc. and the medication should be kept out of reach of children. Lot number X is also included.*
FDA Label Image

30 Capsules (Tizanidine 4mg)

30 Capsules (Tizanidine 4mg)
Each capsule contains 4.58mg of tizanidine hydrochloride equivalent to 4mg tizanidine base. These capsules are dispensed in containers with child-resistant caps and manufactured by Aerbic Pramaceticals Limited. The address of manufacturing is Village Panelav, P.0. Tajpura, Near Baska, Taluka-Halol, Jembi, Panchmatal 369360, Gujarat.*
FDA Label Image

30 Capsules (Tizanidine 6mg)

30 Capsules (Tizanidine 6mg)
Ezch capsule contains 6.87mg of Tizanidine Hydrochloride, USP which is equivalent to 6mg of Tizanidine base. Refer to the package insert for prescribing information. The medication should be dispensed only in containers with child-resistant closures. The product is manufactured by Alerbic Pharmaceuticals Limited at Village Panela, P.. Tapura, Near Baska, Tauke-Halol, Panchmatel 389350, Gujarat, hda. The product is available as 30 capsules and Store at 25°C. It is recommended to keep this medication out of reach of children. The trademark of the product is Zandflex® and it is registered with Aoorda Therapeutics, Inc. Mig. Lic. No. GI989. The lot number of the product is X.*
FDA Label Image

Tizanidine-figure-1.jpg (Tizanidine Figure 1)

Tizanidine-figure-1.jpg (Tizanidine Figure 1)
FDA Label Image

Tizanidine-figure-2.jpg (Tizanidine Figure 2)

Tizanidine-figure-2.jpg (Tizanidine Figure 2)
FDA Label Image

Tizanidine-figure-3.jpg (Tizanidine Figure 3)

Tizanidine-figure-3.jpg (Tizanidine Figure 3)
This text appears to be describing the improvement in Ashworth score due to the use of a medication called tizanidine, taken at a mean dose of 28.8mg. The study appears to have lasted for 3 weeks, and the last observation was carried forward.*
FDA Label Image

Tizanidine-str.jpg (Tizanidine Str)

Tizanidine-str.jpg (Tizanidine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.